drugset / Trial / NCT01065051

Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics

NCT01065051

Phase 2 Terminated 1 enrolled Bayer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to assess whether oral Riociguat affects the left ventricular contractility and relaxation in patients with pulmonary hypertension associated with left ventricular systolic dysfunction

Timeline

Start
2010-11
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Riociguat Other / unclassified 1 mg Oral